Related Experiment Video
Updated: May 14, 2026

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
Published on: March 3, 2023
Increased peritoneal dialysis exit site infections using topical antiseptic polyhexamethylene biguanide compared to
Andrew Findlay1, Charelle Serrano, Sally Punzalan
1Department of Renal Medicine and Transplantation, Barts Health NHS Trust, London, United Kingdom.
Abstract:
Prophylactic mupirocin for peritoneal catheter exit sites reduces exit site infection (ESI) risk but engenders antibiotic resistance. We present early interim safety analysis of an open-label randomized study comparing polyhexamethylene biguanide (PHMB) and mupirocin. A total of 106 patients randomized to 53 in each group were followed up for a mean of 12.68 months per patient. On safety analysis, the PHMB group had a significantly greater ESI rate than the mupirocin group (odds ratio [OR], 0.26; 95% confidence interval [CI], 0.09 to 0.80), leading to discontinuation of the trial.
Insights
Polyhexamethylene biguanide (PHMB) did not effectively prevent peritoneal catheter exit site infections (ESIs) compared to mupirocin. The study found PHMB led to a higher ESI rate, resulting in trial discontinuation.
Area of Science:
- Nephrology
- Infectious Diseases
- Antimicrobial Stewardship
Background:
- Peritoneal catheter exit site infections (ESIs) are a significant complication in patients undergoing peritoneal dialysis.
- Prophylactic mupirocin reduces ESI risk but raises concerns about antibiotic resistance.
- Novel antimicrobial agents are needed to prevent ESIs while mitigating resistance.
Purpose of the Study:
- To compare the safety and efficacy of polyhexamethylene biguanide (PHMB) versus mupirocin for preventing ESIs in peritoneal dialysis patients.
- To assess the exit site infection rate in patients randomized to PHMB or mupirocin prophylaxis.
Main Methods:
- An open-label, randomized study was conducted.
- 106 patients were randomized into two groups: 53 receiving PHMB and 53 receiving mupirocin.
- Patients were followed for a mean of 12.68 months for safety analysis, focusing on ESI rates.
Main Results:
- The PHMB group experienced a significantly higher rate of exit site infections compared to the mupirocin group.
- The odds ratio for ESI in the PHMB group was 0.26 (95% CI, 0.09 to 0.80), indicating a protective effect of mupirocin.
- These interim safety findings led to the discontinuation of the trial.
Conclusions:
- Polyhexamethylene biguanide (PHMB) is less effective than mupirocin in preventing peritoneal catheter exit site infections.
- Mupirocin remains a preferred prophylactic agent for peritoneal catheter exit sites despite resistance concerns.
- Further research into alternative prophylactic strategies is warranted.
Related Concept Videos
Hand hygiene
Hand washing...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Acute Pyelonephritis II: Diagnostic Studies and Management
